49 related articles for article (PubMed ID: 28217023)
1. Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features.
Lima Ferreira J; Marques B; Menke-van der Houven van Oordt CW; de Herder WW; Brabander T; Hofland J
Endocrinol Diabetes Metab Case Rep; 2021 May; 2021():. PubMed ID: 33982661
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid Hormone-Related Peptide-Producing Gallbladder Cancer Presenting With Humoral Hypercalcemia of Malignancy: A Case Report.
Takahashi K; Ohyama H; Ohno I; Takiguchi Y; Kato N
Cureus; 2024 Jan; 16(1):e52951. PubMed ID: 38406045
[TBL] [Abstract][Full Text] [Related]
3. Missed diagnosis of lymphoma presenting with humoral hypercalcemia of malignancy due to cessation of oncological workup after negative computed tomography scans.
Altshuler E; Aryan M; King W; Otero R
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34969803
[TBL] [Abstract][Full Text] [Related]
4. 68Ga-DOTATATE PET/CT Detected Bone Metastasis Earlier Than 68Ga-FAPI PET/CT and 99mTc-MDP Bone Scintigraphy in a Patient With Nasopharyngeal Carcinoma.
Zheng J; Zhu H; Shao Z; Miao W
Clin Nucl Med; 2024 May; ():. PubMed ID: 38768089
[TBL] [Abstract][Full Text] [Related]
5. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
Behdadnia A; Jeddi M
J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
[TBL] [Abstract][Full Text] [Related]
6. A Case of Fibroblast Growth Factor Receptor Fusion-Positive Intrahepatic Cholangiocarcinoma With Humoral Hypercalcemia of Malignancy.
Chauhan A; Likasitwatanakul P; Ahmed A; Sibley SD
Cureus; 2024 Apr; 16(4):e58741. PubMed ID: 38779292
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma Presenting as Humoral Hypercalcemia of Malignancy: A Case Report and Literature Review.
Erdinc B; Ramachandran P; Yadav R; Sahni S; Joseph G
Cureus; 2019 Dec; 11(12):e6481. PubMed ID: 32025405
[TBL] [Abstract][Full Text] [Related]
8. The Utility of Gallium-68 PET/CT in MEN1 Related Parathyroid Disease.
Storan D; Almeamar H; Flynn S; Sherlock M; Colombie M; Skehan SJ; Crowley RK
Eur J Endocrinol; 2024 May; ():. PubMed ID: 38781437
[No Abstract] [Full Text] [Related]
9. Reply to: The Utility of Gallium-68 PET/CT in MEN1 Related Parathyroid Disease.
Kostiainen I; Schildt J; Parviainen H; Ryhänen EM; Schalin-Jäntti C
Eur J Endocrinol; 2024 Jun; ():. PubMed ID: 38828659
[No Abstract] [Full Text] [Related]
10. What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Ragni A; Zanata I; Colao A; Faggiano A
J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294693
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine neoplasia and bone (Review).
Ghemigian A; Carsote M; Sandru F; Petca RC; Oproiu AM; Petca A; Valea A
Exp Ther Med; 2021 Nov; 22(5):1219. PubMed ID: 34584564
[TBL] [Abstract][Full Text] [Related]
12. Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report.
Haemels M; Delaunoit T; Van Laere K; Van Cutsem E; Verslype C; Deroose CM
BMC Gastroenterol; 2020 Oct; 20(1):324. PubMed ID: 33008295
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture.
Slouma M; Abbes M; Dhahri R; Litaiem N; Gueddiche N; Mansouri N; Msekni I; Gharsallah I; Metoui L; Louzir B
Clin Rheumatol; 2021 Feb; 40(2):775-782. PubMed ID: 32666178
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Bone Disease in the Context of Metastatic Neuroendocrine Tumor: Differentiation from Skeletal Metastasis, the Molecular PET-CT Imaging Features, and Exploring the Possible Etiopathologies Including Parathyroid Adenoma (MEN1) and Paraneoplastic Humoral Hypercalcemia of Malignancy Due to PTHrP Hypersecretion.
Ranade R; Basu S
World J Nucl Med; 2017; 16(1):62-67. PubMed ID: 28217023
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hitherto unknown brain meningioma detected on
Parghane RV; Talole S; Basu S
World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
[TBL] [Abstract][Full Text] [Related]
16. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
17. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
18. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
19. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
